Browsing by Author "Bondarenko, Igor"
Now showing items 1-3 of 3
-
Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%: EMPOWER-Lung 1 subgroup analysis.
Gladkov, Oleg; Rietschel, Petra; Gullo, Giuseppe; Bentsion, Dmitry; Clingan, Philip R.; Lowy, Israel; Seebach, Frank A.; Lee, Sue; Pouliot, Jean-Francois; McGinniss, Jennifer; Rizvi, Naiyer A.; Sriuranpong, Virote; Ozguroglu, Mustafa; Sezer, Ahmet; Kilickap, Saadettin; Gumus, Mahmut; Bondarenko, Igor; Gogishvili, Miranda; Turk, Haci M.; Cicin, Irfan (2021-05-01) -
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Sezer, Ahmet; Kilickap, Saadettin; Gümüş, Mahmut; Bondarenko, Igor; Özgüroğlu, Mustafa; Gogishvili, Miranda; Turk, HACI MEHMET; Cicin, Irfan; Bentsion, Dmitry; Gladkov, Oleg; Clingan, Philip; Sriuranpong, Virote; Rizvi, Naiyer; Gao, Bo; Li, Siyu; Lee, Sue; McGuire, Kristina; Chen, Chieh-I; Makharadze, Tamta; Paydas, Semra; Nechaeva, Marina; Seebach, Frank; Weinreich, David M; Yancopoulos, George D; Gullo, Giuseppe; Lowy, Israel; Rietschel, Petra (2021-02-13) -
Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 >= 50%: Results from EMPOWER-Lung 1 study.
Gumus, Mahmut; Mastey, Vera; Harnett, James; Sezer, Ahmet; Chen, Chieh-I; Cicin, Irfan; Turk, Haci M.; Gogishvili, Miranda; Ozguroglu, Mustafa; Bondarenko, Igor; Kilickap, Saadettin; Ivanescu, Cristina; Naumann, Ulrike; Reaney, Matthew; Konidaris, Gerasimos; Sasane, Medha; Brady, Keri; Li, Siyu; Gullo, Giuseppe; Rietschel, Petra (2021-05-01)
